| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| July 23rd, 2004 | 17 | Yes |
Popular Name: 4-(6-methyl-1,3-benzothiazol-2-yl)aniline 4-(6-methyl-1,3-benzothiazol-2-y…
2-(4-Aminophenyl)-6-methylbenzothiazole
2-(p-aminophenyl)-6-methyl-Benzothiazole
4-(6-methyl-1,3-benzothiazol-2-yl)phenylamine
4-(6-methyl-2-benzothiazolyl)aniline
4-(6-Methyl-2-benzothiazolyl)benzeneamine
4-(6-Methyl-benzothiazol-2-yl)-phenylamine
benzenamine, 4-(6-methyl-2-benzothiazolyl)-
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 3.79 | 6.3 | -8.5 | 2 | 2 | 0 | 39 | 240.331 | 1 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| MP | 188-193° | Oakwood Chemical |
| MP | 191 - 196 | Enamine Building Blocks |
| MP | 194 - 196 | Enamine Building Blocks |
| MP | 194...196 | Enamine Building Blocks |
| BP | 434° | Oakwood Chemical |
| purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
| Purity | 95% | Fluorochem |
| Warnings | IRRITANT | Matrix Scientific |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| A4-2-E | Beta Amyloid A4 Protein (cluster #2 Of 5), Eukaryotic | Eukaryotes | 10 | 0.66 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| A4_HUMAN | P05067 | Beta Amyloid A4 Protein, Human | 9.5 | 0.66 | Binding ≤ 1μM |
| A4_HUMAN | P05067 | Beta Amyloid A4 Protein, Human | 9.5 | 0.66 | Binding ≤ 10μM |
| Description | Species |
|---|---|
| Advanced glycosylation endproduct receptor signaling | |
| Amyloids | |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | |
| ECM proteoglycans | |
| Formyl peptide receptors bind formyl peptides and many other ligands | |
| G alpha (i) signalling events | |
| G alpha (q) signalling events | |
| Platelet degranulation | |
| RIP-mediated NFkB activation via ZBP1 | |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
| The NLRP3 inflammasome | |
| TRAF6 mediated NF-kB activation |